Severe somatic symptoms | Severe psychological symptoms | Severe urogenital symptoms | |||||||
---|---|---|---|---|---|---|---|---|---|
Crude | Adjusteda | Crude | Adjusteda | Crude | Adjusteda | ||||
N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | |
Pre-menopause (N = 44) | 2 (4.5%) | 1 | 1 | 6 (13.6%) | 1 | 1 | 3 (6.8%) | 1 | 1 |
Peri-menopause (N = 70) | 7 (10.0%) | 2.33 [0.46–11.82] | 3.79 [0.79–18.24] | 13 (18.6%) | 1.44 [0.54–3.89] | 2.31 [0.79–6.80] | 6 (8.6%) | 1.28 [0.38–5.22] | 1.00 [0.27–3.74] |
Post-menopause (N = 137) | 10 (7.3%) | 1.65 [0.31–8.82] | 2.35 [0.45–12.86] | 28 (20.4%) | 1.63 [0.54–4.88] | 1.96 [0.47–8.08] | 34 (24.8%) | 4.51 [1.42–14.3] | 4.90 [1.74–13.84] |
p value | 0.554 | 0.602 | 0.002 |